Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 210

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Non‐THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro‐apoptotic effects and underlying mechanisms

Open access
De Petrocellis, Luciano, Ligresti, Alessia, Schiano Moriello, Aniello, Iappelli, Mariagrazia, Verde, Roberta, Stott, Colin G, Cristino, Luigia, Orlando, Pierangelo, Di Marzo, Vincenzo·2013·British Journal of Pharmacology

Abstract

BACKGROUND AND PURPOSE: Cannabinoid receptor activation induces prostate carcinoma cell (PCC) apoptosis, but cannabinoids other than Δ 9‐tetrahydrocannabinol (THC), which lack potency at cannabinoid receptors, have not been investigated. Some of these compounds antagonize transient receptor potential melastatin type‐8 (TRPM8) channels, the expression of which is necessary for androgen receptor (AR)‐dependent PCC survival. EXPERIMENTAL APPROACH: We tested pure cannabinoids and extracts from Cannabis strains enriched in particular cannabinoids (BDS), on AR‐positive (LNCaP and 22RV1) and ‐negative (DU‐145 and PC‐3) cells, by evaluating cell viability (MTT test), cell cycle arrest and apoptosis induction, by FACS scans, caspase 3/7 assays, DNA fragmentation and TUNEL, and size of xenograft tumours induced by LNCaP and DU‐145 cells. KEY RESULTS: Cannabidiol (CBD) significantly inhibited cell viability. Other compounds became effective in cells deprived of serum for 24 h. Several BDS were more potent than the pure compounds in the presence of serum. CBD‐BDS (i.p.) potentiated the effects of bicalutamide and docetaxel against LNCaP and DU‐145 xenograft tumours and, given alone, reduced LNCaP xenograft size. CBD (1–10 µM) induced apoptosis and induced markers of intrinsic apoptotic pathways (PUMA and CHOP expression and intracellular Ca 2+). In LNCaP cells, the pro‐apoptotic effect of CBD was only partly due to TRPM8 antagonism and was accompanied by down‐regulation of AR, p53 activation and elevation of reactive oxygen species. LNCaP cells differentiated to androgen‐insensitive neuroendocrine‐like cells were more sensitive to CBD‐induced apoptosis. CONCLUSIONS AND IMPLICATIONS: These data support the clinical testing of CBD against prostate carcinoma. LINKED ARTICLE This article is commented on by Pacher et al., pp. 76–78 of this issue. To view this commentary visit http://dx.doi.org/10.1111/j.1476‐5381.2012.02121.x

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2012.02027.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

Metadata

Authors
De Petrocellis, L., Ligresti, A., Schiano Moriello, A., Iappelli, M., Verde, R., Stott, C. G., Cristino, L., Orlando, P., & Di Marzo, V.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2012-12-18
Volume
168
Issue
1
Pages
79-102
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1485494169
Cited by
210
References
6
FWCI
3.72
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.